A detailed history of Sage Capital Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Sage Capital Management, LLC holds 3,433 shares of ABT stock, worth $395,824. This represents 0.19% of its overall portfolio holdings.

Number of Shares
3,433
Previous 3,427 0.18%
Holding current value
$395,824
Previous $356 Million 9.89%
% of portfolio
0.19%
Previous 0.19%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$100.07 - $118.13 $600 - $708
6 Added 0.18%
3,433 $391 Million
Q2 2024

Jul 29, 2024

BUY
$100.73 - $112.44 $345,201 - $385,331
3,427 New
3,427 $356 Million
Q1 2024

Jul 31, 2024

SELL
$109.52 - $120.96 $547 - $604
-5 Reduced 0.15%
3,422 $389 Million
Q4 2023

Jul 31, 2024

SELL
$90.19 - $110.4 $901 - $1,104
-10 Reduced 0.29%
3,417 $376 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $202B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Sage Capital Management, LLC Portfolio

Follow Sage Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sage Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sage Capital Management, LLC with notifications on news.